HomeAmgen says Lumakras cuts risk of lung cancer progression by 34%Amgen Inc. cancer drug, Lumakras, is displayed in its packaging

Amgen Inc. cancer drug, Lumakras, is displayed in its packaging

Amgen Inc. cancer drug, Lumakras, is displayed in its packaging at Thousand Oaks, in California, United States September 10, 2022. Amgen/Handout via REUTERS
- Advertisment -
Google search engine

Most Read